| Date Filed | Type | Description |
| 03/02/2023 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 2,259 shares
@ $8.85, valued at
$20k
|
|
| 12/19/2022 |
4
| INGRAM ROBERT ALEXANDER (FORMER DIRECTOR) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 9,375 shares
@ $1.5, valued at
$14.1k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 6,584 shares
@ $2.62, valued at
$17.3k
|
|
| 09/02/2022 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,438 shares
@ $13.9, valued at
$20k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 505 shares
@ $34.29, valued at
$17.3k
|
|
| 12/02/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 3,669 shares
@ $5.11, valued at
$18.7k
|
|
| 10/01/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $30.457, valued at
$152.3k
|
|
| 09/29/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 29,842 options to buy
@ $29.65, valued at
$884.8k
|
|
| 09/29/2020 |
3
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 3 on Black Diamond Therapeutics, Inc. |
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Novan, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.78, valued at
$15.6k
|
|
| 06/03/2020 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 4,171 shares
@ $4.495, valued at
$18.7k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 6,578 shares
@ $2.85, valued at
$18.7k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 6,270 shares
@ $2.99, valued at
$18.7k
|
|
| 08/02/2019 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Novan, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.63, valued at
$52.6k
|
|
|